CTT PHARMACEUTICAL HOLDINGS, INC. purchased $114 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 2,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-15.
How this was made
The 30-second read
Why it matters
The transaction is unlikely to move the stock materially but adds a data point for monitoring insider activity.
Market read
Low relevance; the insider purchase is small and unlikely to affect trading decisions.
What to watch
Potential upcoming corporate actions or financing that prompted the purchase are not disclosed.
Background
Form 4 filings disclose insider transactions; this filing reports a modest purchase by the CEO.
Ticker impact
CEO purchased 2,000 shares at $0.057 each, a $114 insider buy disclosed on Form 4.
slight upward bias as market may view the purchase as a confidence signal
The purchase is very small relative to total shares outstanding; impact on price is expected to be minimal.
Market effects
None significant for the pharmaceutical sector.
No regional effect.
Limited to CTTH shareholders.
Counterpoint
Given the tiny size, the buy may be routine compensation rather than a strong confidence signal.
Key entities
- CompanyCTT Pharmaceutical Holdings, Inc.
Issuer of the Form 4 filing.
- PersonCEO (unnamed)
Insider who purchased shares.